Cannabidiol in inflammatory bowel diseases: a brief overview.
about
Marijuana: current concepts(†)Adverse health effects of marijuana useRole of Cannabinoids in Gastrointestinal Mucosal Defense and InflammationInverted U-Shaped Dose-Response Curve of the Anxiolytic Effect of Cannabidiol during Public Speaking in Real Life.Chronic administration of Δ9-tetrahydrocannabinol induces intestinal anti-inflammatory microRNA expression during acute simian immunodeficiency virus infection of rhesus macaquesThe implications of marijuana legalization in ColoradoAn Orally Active Cannabis Extract with High Content in Cannabidiol attenuates Chemically-induced Intestinal Inflammation and Hypermotility in the Mouse.Phytochemicals and their potential usefulness in inflammatory bowel disease.Cannabinoids for treating inflammatory bowel diseases: where are we and where do we go?Legalizing and Regulating Marijuana in Canada: Review of Potential Economic, Social, and Health Impacts.Anti-Inflammatory Activity in Colon Models Is Derived from Δ9-Tetrahydrocannabinolic Acid That Interacts with Additional Compounds in Cannabis Extracts.Inverse association of marijuana use with nonalcoholic fatty liver disease among adults in the United States.Marijuana Use and Organ Transplantation: a Review and Implications for Clinical Practice.Phytocannabinoids modulate emotional memory processing through interactions with the ventral hippocampus and mesolimbic dopamine system: implications for neuropsychiatric pathology.No Acute Effects of Cannabidiol on the Sleep-Wake Cycle of Healthy Subjects: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study.Maternal administration of cannabidiol promotes an anti-inflammatory effect on the intestinal wall in a gastroschisis rat model.
P2860
Q21090461-C0E5E393-BFA0-4CE6-BDCF-81C29E5D90D0Q26861513-421D1720-B3C4-4FD7-9855-369A921FD4AAQ30357558-B7D4B22D-A1D4-49BA-82E8-B2D6510D0C95Q33658933-D08D9F97-52D8-4E67-BB09-22E2D38980CAQ34991150-403029DD-59EF-422F-98C9-EEB8EAF7CD06Q35500385-924DB082-A74A-4A63-81B3-02AA6BE92DE5Q37306421-78E763D4-CFEC-4C71-8BBE-2C3ECE4CE338Q38312093-758DE88B-5A8B-4E13-8284-EA9B0728A17AQ38918638-2F9BBC25-18C0-4B7A-BC53-DAABF3C58980Q42390419-63033193-6E02-4678-80A1-0A7686007A0CQ42714629-1C0D4ED6-64A6-495A-A2C3-78B625E89C76Q46480886-D8BAA33A-782F-41A5-822C-E4A8375D9639Q47637125-2520F856-DEF4-4701-B3DF-B49AFD1D2E11Q48139337-1F0F2070-61E1-4D69-B811-18B3DE675EBBQ55120181-20A5FF6D-650B-47EB-A27D-549D8B3A8F80Q55379948-71375D45-BCF7-4AD0-B74B-7780ACA1BC9C
P2860
Cannabidiol in inflammatory bowel diseases: a brief overview.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Cannabidiol in inflammatory bowel diseases: a brief overview.
@en
type
label
Cannabidiol in inflammatory bowel diseases: a brief overview.
@en
prefLabel
Cannabidiol in inflammatory bowel diseases: a brief overview.
@en
P2093
P2860
P50
P921
P356
P1476
Cannabidiol in inflammatory bowel diseases: a brief overview.
@en
P2093
Carla Cirillo
Daniele De Filippis
Elena Capoccia
Teresa Iuvone
P2860
P304
P356
10.1002/PTR.4781
P577
2012-07-20T00:00:00Z